Abstract
Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment.
S Guis, J Jouglard, G Kozak-Ribbens, D Figarella-Branger, D Vanuxem, J F Pellissier and P J Cozzone
The Journal of Rheumatology June 2001, 28 (6) 1405-1406;
S Guis
J Jouglard
G Kozak-Ribbens
D Figarella-Branger
D Vanuxem
J F Pellissier
In this issue
Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment.
S Guis, J Jouglard, G Kozak-Ribbens, D Figarella-Branger, D Vanuxem, J F Pellissier, P J Cozzone
The Journal of Rheumatology Jun 2001, 28 (6) 1405-1406;